Enliven Therapeutics, Inc. Soared
Thu, Jan 08, 2026 at 07:31 PM
Enliven Therapeutics, Inc. (ELVN:NASDAQ) shot up at $23.25, a gain of 50.3%. On Thu, Jan 08, 2026, ELVN:NASDAQ touched a New 2-Week High of $23.25. The stock appeared on our News Catalysts scanner on Thu, Jan 08, 2026 at 04:50 PM in the 'MISCELLANEOUS' category. From Fri, Dec 26, 2025, the stock recorded 37.50% Up Days and 44.44% Green Days
About Enliven Therapeutics, Inc. (ELVN:NASDAQ)
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially best-in-class or first-in-class precision oncology therapies.
Top 10 Gainers:
- flyExclusive, Inc. (FLYX:NYSEMKT), 130.26%
- Creative Global Technology Holdings Limited (CGTL:NASDAQ), 122.91%
- Pineapple Financial Inc. (PAPL:NYSEMKT), 56.64%
- Enliven Therapeutics, Inc. (ELVN:NASDAQ), 50.29%
- AgEagle Aerial Systems, Inc. (UAVS:NYSEMKT), 45%
- Murano Global Investments Plc (MRNO:NASDAQ), 43.4%
- Aclarion, Inc. (ACON:NASDAQ), 42.09%
- Century Therapeutics, Inc. (IPSC:NASDAQ), 36.15%
- Nuvve Holding Corp. (NVVE:NASDAQ), 34.19%
- Ping An Biomedical Co Ltd Ord Shs (PASW:NASDAQ), 33.95%